The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites P20 planning grant applications for developing collaborative partnerships between institutions serving health disparity populations and underrepresented students (ISUPSs) and NCI-designated Cancer Centers (or Cancer Centers with highly integrated cancer research programs). This FOA is designed to facilitate the planning and execution of focused collaborations in cancer-related research, research experience, and research education. A major goal of the NCI P20 partnership programs is to provide support for investigators at ISUPSs and Cancer Centers to conduct cancer research pilot projects and cancer research education programs. The purpose of the pilot projects and education programs is to allow awardees to obtain preliminary data that will lead to competitive grant applications for funding by the NIH/NCI and/or other Federal/Non-Federal agencies.
- Letters of Intent: 30 days prior to the application due date
- Applications: Jan. 6, 2023
PAR-22-239 Expiration Date: January 07, 2023
Program Faculty: Researchers from diverse backgrounds, including underrepresented racial and ethnic groups, persons with disabilities, and women who serve as faculty are encouraged to apply. Faculty should have research expertise and experience relevant to the proposed program and demonstrate a history of, or the potential for, their intended roles.
Participants: Unless strongly justified on the basis of exceptional relevance to NIH, research education programs should be used primarily for the education of U.S. citizens and permanent residents. Participants supported through the C-REP may include students (i.e., high school, undergraduate, graduate), post-doctoral fellows, Early-Stage Investigators (ESIs) and other less-experienced investigators.
Number of concurrent applications/awards. The PACHE Program includes the P20 grant mechanism (this FOA) and the U54 (PAR-22-249) Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE). Each ISUPS and Cancer Center may not have more than one P20 award and one U54 award simultaneously with the same partnering institutions. However, the partnering institutions can establish and apply for P20 partnerships with different partnering institutions and different PDs/PIs.
The combined budget of direct costs for ISUPS and CC cannot exceed $375,000 per year.
Applicants may apply for up to 4 years of support.